These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6942182

  • 1. In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
    Iglehart JD, Ward EC, Huper G, Thiel K, Bolognesi DP.
    J Natl Cancer Inst; 1981 Jul; 67(1):117-22. PubMed ID: 6942182
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC, Iglehart JD, Weinhold KJ, Bolognesi DP.
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [Abstract] [Full Text] [Related]

  • 5. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B, Manohar V, Sugimoto T, Ashley MP, Kato Y, Rappaport P.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [Abstract] [Full Text] [Related]

  • 6. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK, Donahoe RM, Huang KY, Sass B, Peters RL, Kelloff GJ.
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [Abstract] [Full Text] [Related]

  • 7. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA, Mayer AM, Pasqualini CD.
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [Abstract] [Full Text] [Related]

  • 8. Infectivity of Friend murine leukemia virus for hamster cells.
    Ishimoto A.
    J Natl Cancer Inst; 1985 Apr; 74(4):905-8. PubMed ID: 3857383
    [Abstract] [Full Text] [Related]

  • 9. Multinucleation in the presence of cytochalasin B by RNA tumor virus-transformed cells.
    Somers KD, Murphey MM.
    Cancer Res; 1980 Dec; 40(12):4410-4. PubMed ID: 6254645
    [Abstract] [Full Text] [Related]

  • 10. In vivo distribution of receptor for ecotropic murine leukemia virus and binding of envelope protein of Friend Murine leukemia virus.
    Yamaguchi S, Hasegawa M, Suzuki T, Ikeda H, Aizawa S, Hirokawa K, Kitagawa M.
    Arch Virol; 2003 Jun; 148(6):1175-84. PubMed ID: 12756622
    [Abstract] [Full Text] [Related]

  • 11. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
    Kitagawa M, Aizawa S, Kamisaku H, Sado T, Ikeda H, Hirokawa K.
    Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
    [Abstract] [Full Text] [Related]

  • 12. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
    Robey WG, Kuenzel WJ, Vande Woude GF, Fischinger PJ.
    Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443
    [Abstract] [Full Text] [Related]

  • 13. Cross-species infectivity and pathogenesis of the Friend murine leukemia virus complex in Syrian hamsters.
    Chen X, Da R, Jin X, Song W, Li X, Fu Y, Ling H, Zhong Z, Yamamura K, Ishimoto A, Zhang F.
    Virus Res; 2007 Dec; 130(1-2):281-4. PubMed ID: 17602778
    [Abstract] [Full Text] [Related]

  • 14. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M, Yamaguchi H, Hosokawa M, Mizushima Y, Kobayashi H.
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [Abstract] [Full Text] [Related]

  • 15. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
    Hosokawa M, Okayasu T, Ikeda K, Katoh H, Suzuki Y, Kobayashi H.
    Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
    [Abstract] [Full Text] [Related]

  • 16. The envelopes of two ecotropic murine leukemia viruses display distinct efficiencies in retroviral vaccination by interference.
    Corbin A, Richardson J, Denesvre C, Pozo F, Ellerbrok H, Sitbon M.
    Virology; 1994 Jul; 202(1):70-5. PubMed ID: 8009868
    [Abstract] [Full Text] [Related]

  • 17. Suppression of the immune response in tumor-bearing mice. I. Response to virus-producing tumor cells and non-virus-producing tumor cells.
    Bluestone JA, Lopez C.
    J Natl Cancer Inst; 1979 Nov; 63(5):1215-20. PubMed ID: 228105
    [Abstract] [Full Text] [Related]

  • 18. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
    Howard J, Ung Y, Adachi D, Ben-David Y.
    Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
    [Abstract] [Full Text] [Related]

  • 19. Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population.
    Zbar B, Terata N, Nagai A, Tanio Y, Hovis J.
    Cancer Res; 1984 Oct; 44(10):4622-9. PubMed ID: 6088041
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T, Sussman JJ, Krinock RA, Chang AE, Shu S.
    Cancer Res; 1994 May 15; 54(10):2744-50. PubMed ID: 8168105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.